Cronos Group
(NASDAQ:CRON)
$2.65
0[0.00%]
At close: May 7
$2.65
0[0.00%]
After Hours: 5:43PM EDT
Q1 2024 earnings tomorrow on Thu May 9th before the market open
Conference call scheduled tomorrow at 8:30 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Cronos Group Stock (NASDAQ:CRON), Quotes and News Summary

Cronos Group Stock (NASDAQ: CRON) stock price, news, charts, stock research, profile.

Open$2.640
Close$2.640
Volume / Avg.1.600M / 3.293M
Day Range2.600 - 2.680
52 Wk Range1.640 - 2.990
Market Cap$1.012B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
0
Short Interest
2.81%
Days to Cover1.31

Recent News

Canadian Marijuana Company Cronos Expands Into UK After Setting Up In Germany's Nascent Market
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Tuesday that it's expanding its medical brand, PEACE NATURALS, into the United Kingdom market with its first shipment of cannabis flower to GROW Pharma.The Toronto-based cannabis company has partnered with a distributor of prescribed medicinal cannabis products in the UK after years of investing in research and development, tissue culture, and its cannabis genetics breeding program.The debut in the UK follows the company's expansion in Germany and Australia last year, after successfully expanding across Canada and Israel.
Jelena Martinovic
Why Cronos Group Shares Are Falling
Cronos Group shares are trading lower by 3.3% during Tuesday's session. Shares of cannabis stocks are trading lower in sympathy with Tilray.
Henry Khederian
NASDAQ-Listed Marijuana Stocks, Tilray, Canopy, Aurora Rally: What's Behind The Surge?
The Canadian cannabis sector is witnessing a notable upswing, driven by recent developments including Tilray's (NASDAQ: TLRY) earnings report, Organigram's investor day (NASDAQ: OGI) and pivotal movements by Canopy Growth (NASDAQ:
Nicolás Jose Rodriguez
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
1.3
Strong Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRON

FAQ

Q

How do I buy Cronos Group (CRON) stock?

A

You can purchase shares of Cronos Group (NASDAQ: CRON) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cronos Group's (CRON) competitors?

A

There are no as such competitors for Cronos Group.

Q

What is the target price for Cronos Group (CRON) stock?

A

The latest price target for Cronos Group (NASDAQ: CRON) was reported by B of A Securities on Monday, April 8, 2024. The analyst firm set a price target for 2.50 expecting CRON to fall to within 12 months (a possible -5.66% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cronos Group (CRON)?

A

The stock price for Cronos Group (NASDAQ: CRON) is $2.65 last updated May 7, 2024 at 5:43 PM EDT.

Q

Does Cronos Group (CRON) pay a dividend?

A

There are no upcoming dividends for Cronos Group.

Q

When is Cronos Group (NASDAQ:CRON) reporting earnings?

A

Cronos Group’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Cronos Group (CRON) going to split?

A

There is no upcoming split for Cronos Group.

Q

What sector and industry does Cronos Group (CRON) operate in?

A

Cronos Group is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.